Filing Details
- Accession Number:
- 0000899243-21-019687
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-17 21:08:32
- Reporting Period:
- 2021-05-17
- Accepted Time:
- 2021-05-17 21:08:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1680367 | Shattuck Labs Inc. | STTK | Pharmaceutical Preparations (2834) | 812575858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1827204 | R Andrew Neill | C/O Shattuck Labs, Inc. 500 W. 5Th Street, Suite 1200 Austin TX 78701 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-05-17 | 2,000 | $26.27 | 57,963 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.91 to $26.61. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.